Common Data Elements Analysis of Mechanical Thrombectomy Clinical Trials for Acute Ischemic Stroke with Large Core Infarct

Background Clinical trials addressing large core acute ischemic stroke (AIS) are ongoing across multiple international groups. Future development of clinical guidelines depends on meta-analyses of these trials calling for a degree of homogeneity of elements across the studies. This common data eleme...

Full description

Saved in:
Bibliographic Details
Published in:Clinical neuroradiology (Munich) 2023-06, Vol.33 (2), p.307-317
Main Authors: Jabal, Mohamed Sobhi, Ibrahim, Mohamed K., Thurnham, Jade, Kallmes, Kevin M., Kobeissi, Hassan, Ghozy, Sherief, Hardy, Nicole, Tarchand, Ranita, Bilgin, Cem, Heit, Jeremy J., Brinjikji, Waleed, Kallmes, David F.
Format: Article
Language:English
Subjects:
Brain Ischemia - diagnostic imaging
Brain Ischemia - surgery
Clinical trials
Common Data Elements
Humans
Infarction - complications
Ischemic Stroke - complications
Medicine
Medicine & Public Health
Mortality
Neurology
Neuroradiology
Neurosurgery
Review Article
Stroke - diagnostic imaging
Stroke - surgery
Thrombectomy - adverse effects
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Clinical trials addressing large core acute ischemic stroke (AIS) are ongoing across multiple international groups. Future development of clinical guidelines depends on meta-analyses of these trials calling for a degree of homogeneity of elements across the studies. This common data element study aims to provide an overview of key features of pertinent large core infarct trials. Methods PubMed and ClinicalTrials.gov databases were screened for published and ongoing clinical trials assessing mechanical thrombectomy in patients with AIS with large core infarct. Nested Knowledge AutoLit living review platform was utilized to categorize primary and secondary outcomes as well as inclusion and exclusion criteria for patient selection in the trials. Results The most reported data element was ASPECTS score but with varied definitions of what constitutes large core. Non-utility-weighted modified Rankin score (mRS) was reported in 6/7 studies as the primary outcome, while the utility-weighted mRS was the outcome of interest in the TESLA trial, all of them at the 3 months mark, with only LASTE looking for mRS shift at the 6 months mark. Secondary outcomes had more variations. Mortality is reported separately only in 4/7 trials, all at the 3‑month mark. Additionally, the TENSION trial reported the frequency of serious adverse events, including mortality, at the 1‑week and 12-month mark. Discussion Overall, in large core trials there is a large degree of heterogeneity in the collected data elements. Differences in definition and timepoints render reaching a unified standard difficult, which hinders high quality meta-analyses and cohesive evidence-driven synthesis.
ISSN:1869-1439
1869-1447
DOI:10.1007/s00062-022-01239-x